跳至主要内容
临床试验/NCT02448472
NCT02448472已完成不适用

Chinese Epidemiological Study of Severe Sepsis.(CHESS Study)

Jianfeng Xie1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2015年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,000
试验地点
1
主要终点
Mortality

研究概览

简要总结

Sepsis is a common cause for morbidity and mortality in critically ill patients. In USA, the incidence of sepsis is about 3/1000 population. However, the incidence of sepsis varies among different clinic trails. In addition, clinician empirical select antibiotic according to the epidemiology of sepsis, however, the etiology of sepsis is various in different studies. In China, the MDRO is much higher than western country. There is no study about the epidemiology of sepsis in China. Therefore, it is necessary to conduct a study about it in China.

详细描述

Sepsis,especially severe sepsis is a major cause of admission to the intensive care unit (ICU) and death. In USA, the incidence of sepsis is about 3/1000 population. However, the incidence of sepsis varies among different clinic trails. Between 6 and 54% of patients admitted to ICUs have severe sepsis and the mortality rate for these patients varies from 20 to 60%. There is no exactly results of incidence of sepsis in China.

In addition, clinician empirical select antibiotic according to the epidemiology of sepsis, however, the etiology of sepsis is various in different studies. In EPIC II study, the organisms of sepsis include Gram-positive microorganisms (69.8%),Gram-negative microorganisms(62.2%) and fungi (17%). In China, the MDRO is much higher than western country. In contrast to EPIC II study, one study in China showed that the organisms of sepsis include Gram-positive microorganisms (14.5%),Gram-negative microorganisms(62.5%) and fungi (2.2%). Therefore, it is necessary to conduct a study about epidemiology of sepsis in China.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • sepsis patients who admitted into ICU during research period (include patients with sepsis at ICU admission and patients who has new sepsis during ICU period)

排除标准

  • The patients with second sepsis in ICU

结局指标

主要结局

Mortality

时间窗: Sepsis and severe sepsis patients will be assessed up to 90 days

Incidence

时间窗: Patients will be assessed up to 90 days

次要结局

  • etiology(The pathogen of sepsis will be assessed up to 90 days)

研究者

发起方
Jianfeng Xie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jianfeng Xie

Attending

Southeast University, China

研究点 (1)

Loading locations...

相似试验